Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Alnylam Pharmaceuticals, Inc.

NASDAQ: ALNY · Life Sciences · 6 alerts · CIK 1178670

Share price
$159.73Close, Nov 16
Market cap
$21.4B
Shares outstanding
133.94MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Alnylam Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:06 PM ET Form 4
Insider Buying

Alnylam Pharmaceuticals Insider Charles Elliott Sigal Buys $244K of Stock

Charles Elliott Sigal bought 1,600 shares of Alnylam Pharmaceuticals, Inc. at $152.25 a share, worth $244K in total on Nov 10, 2026. Shares held after the trade: 3,600 (+80.0%).

Value
$244K
Shares
1,600
Price
$152.25
Holding change
+80.0%
Trade date
Nov 10, 2026
4:02 PM ET Form 4
Insider Buying

Alnylam Pharmaceuticals Insider Amy W. Schulman Buys $300K of Stock

Amy W. Schulman bought 1,910 shares of Alnylam Pharmaceuticals, Inc. at $156.82 a share, worth $300K in total on Nov 9, 2026. Shares held after the trade: 25,959 (+7.9%).

Value
$300K
Shares
1,910
Price
$156.82
Holding change
+7.9%
Trade date
Nov 9, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.